We are live on ! Find out more
IDXX icon

Idexx Laboratories

306 hedge funds and large institutions have $6.51B invested in Idexx Laboratories in 2014 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 71 increasing their positions, 134 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

142% more call options, than puts

Call options by funds: $3.69M | Put options by funds: $1.52M

6% more capital invested

Capital invested by funds: $6.14B → $6.51B (+$372M)

3% less funds holding

Funds holding: 314306 (-8)

11% less funds holding in top 10

Funds holding in top 10: 98 (-1)

21% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 34

47% less repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 134

Holders
306
Holders Change
-8
Holders Change %
-2.55%
% of All Funds
8.8%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.23%
New
27
Increased
71
Reduced
134
Closed
34
Calls
$3.69M
Puts
$1.52M
Net Calls
+$2.16M
Net Calls Change
-$544K
Name Holding Trade Value Shares
Change
Change in
Stake
FIM
101
Friedberg Investment Management
Texas
$5.01M -$49K -770 -1%
Nisa Investment Advisors
102
Nisa Investment Advisors
Missouri
$4.94M +$38.2K +600 +0.8%
ERSOT
103
Employees Retirement System of Texas
Texas
$4.94M
Comerica Bank
104
Comerica Bank
Texas
$4.89M -$561K -8,826 -11%
WC
105
Woodstock Corp
Massachusetts
$4.65M -$12.7K -200 -0.3%
ASRS
106
Arizona State Retirement System
Arizona
$4.5M +$76.3K +1,200 +2%
DCM
107
Driehaus Capital Management
Illinois
$4.47M +$4.26M +66,980 New
CCMINC
108
Cardinal Capital Management Inc (North Carolina)
North Carolina
$4.42M -$62.8K -988 -1%
FT
109
Fiduciary Trust
Massachusetts
$4.32M -$340K -5,344 -8%
CCM
110
Carderock Capital Management
Maryland
$4.3M -$245K -3,854 -6%
Federated Hermes
111
Federated Hermes
Pennsylvania
$4.26M -$136K -2,140 -3%
FMT
112
First Mercantile Trust
Tennessee
$4.25M
MOACM
113
Mutual of America Capital Management
New York
$4.24M -$44.3K -696 -1%
WCF
114
West Coast Financial
California
$4.11M -$51K -802 -1%
Millennium Management
115
Millennium Management
New York
$4.02M +$2.09M +32,872 +121%
State of Tennessee, Department of Treasury
116
State of Tennessee, Department of Treasury
Tennessee
$4.01M -$3.88M -61,000 -50%
UBS AM
117
UBS AM
Illinois
$3.96M +$38.2K +600 +1%
AQR Capital Management
118
AQR Capital Management
Connecticut
$3.75M -$496K -7,800 -12%
First Manhattan
119
First Manhattan
New York
$3.74M
State Farm Mutual Automobile Insurance
120
State Farm Mutual Automobile Insurance
Illinois
$3.71M
HL
121
HeadInvest LLC
Maine
$3.51M
VOYA Investment Management
122
VOYA Investment Management
Georgia
$3.49M -$236K -3,704 -7%
Grantham, Mayo, Van Otterloo & Co (GMO)
123
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$3.42M -$140K -2,200 -4%
U
124
UBS
Switzerland
$3.35M +$214K +3,358 +7%
ProShare Advisors
125
ProShare Advisors
Maryland
$3.34M +$2.3M +36,248 +263%

IDXX Hedge Fund Activity: Q2 2014 in Review

306 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q2 2014, worth a combined $6.51B — up 6.1% from $6.14B a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of IDXX and 27 opened new positions — a net loss of 7 holders — while 134 trimmed existing stakes and 71 added.

The largest buyer was Norges Bank, adding an estimated $49.3M. The largest seller was William Blair & Company, cutting an estimated $86.4M.

  • 306 institutional investors held Idexx Laboratories (IDXX) as of Q2 2014, down from 314 in Q1 2014.
  • Funds reported $6.51B of Idexx Laboratories stock for Q2 2014, up 6.1% quarter-over-quarter.
  • 27 funds opened new Idexx Laboratories positions in Q2 2014 and 34 closed out, a net change of -7 holders.
  • The largest Idexx Laboratories buyer in Q2 2014 was Norges Bank, an estimated $49.3M added.
  • The largest Idexx Laboratories seller in Q2 2014 was William Blair & Company, an estimated $86.4M sold.

Based on aggregated 13F filings for Q2 2014.